Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Toxin-induced hyperthermic syndromes.

Daniel E Rusyniak1, Jon E Sprague

  • 1Division of Medical Toxicology, Department of Emergency Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA. drusyniak@iupui.edu

The Medical Clinics of North America
|October 18, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gut microbiome modulation of opioid reinforcement in preclinical models: Microbial regulation of reward and motivation.

Brain research bulletin·2026
Same author

The abuse-related effects of illicitly manufactured fentanyls (IMFs): A mini review.

Pharmacology, biochemistry, and behavior·2026
Same author

Mental Health Symptom Screening Among Adult Emergency Department Patients: A Cross-Sectional Study.

Journal of the American College of Emergency Physicians open·2026
Same author

Non-fatal opioid overdose associated predominantly with the benzimidazolone, cychlorphine.

Clinical toxicology (Philadelphia, Pa.)·2025
Same author

Scoping review of associations between cytochrome P450 3A4/5 single nucleotide polymorphisms and risk factors for fentanyl overdose.

Pharmacogenomics·2025
Same author

Pediatric Overdose Deaths Increase as the Fourth Wave of the Opioid Epidemic Creates a Perfect Storm.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG·2025
Same journal

Care Transitions Continue to Evolve.

The Medical clinics of North America·2026
Same journal

Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

The Medical clinics of North America·2026
Same journal

Care Transitions and Value-Based Payment Models in the United States.

The Medical clinics of North America·2026
Same journal

Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

The Medical clinics of North America·2026
Same journal

Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

The Medical clinics of North America·2026
Same journal

Social Determinants of Health: Unique Considerations in Transitions of Care.

The Medical clinics of North America·2026
See all related articles

Toxin-induced hyperthermic syndromes, like serotonin syndrome and neuroleptic malignant syndrome, disrupt body temperature regulation. Early recognition and specific treatments are crucial to prevent fatal outcomes.

Area of Science:

  • Toxicology
  • Pharmacology
  • Emergency Medicine

Background:

  • Toxin-induced hyperthermic syndromes are critical differential diagnoses for patients with fever and muscle rigidity.
  • These syndromes result from disrupted thermogenic mechanisms, leading to excess heat generation and impaired dissipation.
  • Untreated, they can cause fatal hyperthermia and multisystem organ failure.

Purpose of the Study:

  • To differentiate between various toxin-induced hyperthermic syndromes.
  • To outline the distinct triggers and recommended treatments for each syndrome.
  • To highlight diagnostic clues and safe therapeutic options when differentiation is challenging.

Main Methods:

  • Comparative analysis of clinical presentations and pathophysiologies.

Related Experiment Videos

  • Review of triggers, diagnostic criteria, and treatment strategies for serotonin syndrome, neuroleptic malignant syndrome, and malignant hyperthermia.
  • Emphasis on physical examination findings for differential diagnosis.

    • Main Results:

    • Serotonin syndrome: rapid onset after serotonergic agent/stimulant use; treated with antagonists or benzodiazepines.
    • Neuroleptic malignant syndrome: slower onset with neuroleptic agents; treated with dopamine agonists and dantrolene.
    • Malignant hyperthermia: rapid onset with jaw rigidity, often during anesthesia; treated with dantrolene.

    Conclusions:

    • Accurate differentiation of toxin-induced hyperthermic syndromes is essential for effective treatment.
    • Benzodiazepines offer a safe option when serotonin syndrome and neuroleptic malignant syndrome are indistinguishable.
    • Further research into pathophysiology and clinical presentation will improve recognition and treatment strategies.